Profile data is unavailable for this security.
About the company
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is a China-based company principally engaged in the manufacture and distribution of traditional Chinese medicines and pharmaceutical products. The Company primarily sells its products under the Changlong and Qingtong brands. The Company's main products include Hai Kun Shen Xi Jiao Nang, small volume solution, lyophilized powder for injection, power for injection, active pharmaceutical ingredient, sterile active pharmaceutical ingredient, solid pharmacy biochemical drugs and others. The Company also makes short-term investments in the wealth management products. The Company mainly operates its businesses in the domestic market.
- Revenue in HKD (TTM)1.05bn
- Net income in HKD206.93m
- Incorporated1996
- Employees798.00
- LocationJilin Province Huinan Changlong Bio-pharmacy Co LtdNo. 31 Beishan StreetChaoyang Town, Huinan CountyTONGHUA 135100ChinaCHN
- Phone+86 4 358218333
- Fax+86 4 358210005
- Websitehttp://www.jlchanglong.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhongzhi Pharmaceutical Holdings Ltd | 2.27bn | 23.25m | 639.06m | 2.49k | 26.86 | 0.5204 | 4.44 | 0.2816 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 880,727.40 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
| Fusen Pharmaceutical Co Ltd | 272.55m | -197.89m | 657.98m | 1.05k | -- | 1.68 | -- | 2.41 | -0.2677 | -0.2677 | 0.3687 | 0.5301 | 0.1875 | 1.11 | 4.05 | 240,982.60 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Uni-Bio Science Group Ltd | 589.59m | 91.35m | 680.72m | 504.00 | 7.48 | 1.78 | 5.95 | 1.15 | 0.0152 | 0.0152 | 0.0976 | 0.0641 | 1.13 | 3.62 | 9.18 | 1,210,657.00 | 17.51 | 6.21 | 22.17 | 8.56 | 82.19 | 80.72 | 15.49 | 4.96 | 3.22 | 59.39 | 0.22 | 1,633.58 | 14.08 | 21.43 | 16.79 | 102.04 | 32.65 | -- |
| Pak Fah Yeow International Ltd | 199.03m | 70.97m | 747.94m | 100.00 | 10.54 | 1.06 | 9.64 | 3.76 | 0.2277 | 0.2277 | 0.6386 | 2.26 | 0.2227 | 1.84 | 24.74 | 1,877,594.00 | 7.94 | 5.03 | 8.68 | 5.24 | 87.44 | 82.23 | 35.66 | 23.92 | 6.21 | 7.72 | 0.0068 | 94.02 | -8.64 | 9.89 | -25.14 | 16.88 | 16.37 | -8.84 |
| Modern Chinese Medicine Group Co Ltd | 228.68m | 21.46m | 835.20m | 190.00 | 32.43 | 1.27 | 24.01 | 3.65 | 0.0358 | 0.0358 | 0.3811 | 0.9152 | 0.392 | 5.89 | 7.49 | 1,203,582.00 | 3.68 | 14.83 | 3.93 | 17.56 | 24.57 | 38.44 | 9.38 | 17.92 | 7.80 | 21.30 | 0.0003 | 2.85 | -37.78 | -0.4333 | -80.18 | -26.87 | 112.81 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.44bn | 97.81m | 859.70m | 1.04k | 8.79 | 0.4424 | 4.27 | 0.5985 | 0.1661 | 0.1661 | 2.44 | 3.30 | 0.5181 | 2.64 | 9.17 | 1,405,524.00 | 2.32 | 13.85 | 2.99 | 18.24 | 53.10 | 59.37 | 4.48 | 35.22 | 0.7111 | 7.99 | 0.1179 | 2.97 | 32.95 | 2.81 | 457.55 | -5.81 | -10.46 | -4.28 |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 968.96m | 49.00 | 24.69 | 0.7958 | -- | 25.43 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Transcenta Holding Ltd | 10.64m | -301.23m | 1.06bn | 171.00 | -- | 1.31 | -- | 99.79 | -0.7435 | -0.7435 | 0.0262 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,826.02 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| 3D Medicines Inc | 507.11m | -190.57m | 1.09bn | 183.00 | -- | 1.35 | -- | 2.16 | -0.7779 | -0.7779 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,655,023.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 206.93m | 1.15bn | 798.00 | 5.58 | 0.589 | 4.80 | 1.10 | 0.3694 | 0.3694 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,136.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.35bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
Data as of Feb 13 2026. Currency figures normalised to Jilin Province Huinan Changlong Bio-pharmacy Co Ltd's reporting currency: Hong Kong Dollar HKD
0.02%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investments Internationalas of 30 Jun 2025 | 32.00k | 0.02% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
